1Dray X, Marteau P. The use of enteral nutrition in the management of Crohn's disease in adults [ J ]. JPEN J Parenter Enteral Nutr,2005,29(4 Suppl):S166- 9,discussion 169- 172,184-188.
3Griffiths AM, Ohlsson A, Sherman PM, et al. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease[ J].Gastroenterology, 1995,108 (4) : 1056 - 1067.
4Femandez-Banares F, Cabre E, Esteve-Comas M, et al. How effective is enteral nutrition in inducing clinical remission in active Crehn's disease? A meta-analysis of the randomized clinical trials [ J ]. JPEN J Parenter Enteral Nutr, 1995,19( 5 ) :356 - 364.
5Messofi A, Trallori G, D'Albasio G, et al. Defined-formula diets versus steroids in the treatment of active Crohn's disease:a meta-anal-ysis [ J ]. Scand J Gastroenterol, 1996,31 ( 3 ) : 267 - 272.
6Gassull MA, Femandez-Banares F, Cabre E, et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease:results of a double blind randomised multicentre European trial[J]. Gut,2002,51 (2) :164 - 168.
7Munkholm P, Langholz E, Davidsen M, et al. Frequency of glucocorticoid resistance and dependency in Crohn's disease [ J ]. Gut,1994,35(3) :360 -362.
8Esaki M, Matsumoto T, Hizawa K. Preventive effect of nutritional therapy against postoperative recurrence of Crohns disease, with reference to findings determined by intra-operative enteroscopy[ J ]. Scand J Gastroenterol, 2005,40 ( 12 ) : 1431 - 1437.
9Fukuda Y,Kosaka T,Okui M,et al. Efficacy of nutritional therapy for active Crohn's disease [ J ]. J Gastroenterol, 1995,30 ( Suppl 8) :83 -87.
10Aghdassi E, Wendland BE, Steinhart AH, et al. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress, a randomized controlled trial [ J ]. Am J Gastroenterol,2003,98 ( 2 ) :348 - 353.
3Fuller R.Probiotics in human medicine[J].Gut,1991,32:439-442.
4Dotan I,Rachmilewitz D.Probiotics in inflammatory bowel disease:possible mechanisms of action[J].Curr Opin Gastroenterol,2005,21 (4):426-430.
5Rembacken B J,Snelling AM,Hawkey PM,et al.Non-pathogenic escherichia coli versus mesalazine for the treatment of ulcerativecolitis:a randomized trial[J].Lancet,1999,354:635-639.
6Madsen KL.The use of probiotics in gastrointestinal disease[J].Can J Gastroenterol,2001,15:817 -822.
7Guslandi M,Giollo P,Testoni PA.A pilot trial of saccharomyces boulardii in ulcerative colitis[J].Eur J Gastroenterol Hepatol,2003,15 (6):697-698.
8Furrie E,S Macfarlane,Kennedy A,et al.Synbiotic therapy(Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis:a randomized controlled pilot trial[J].Gut,2005,54 (9):1346.
9Guslandi M,Mezzi G,Sorghi M,et al.Saccharomyces boulardii in maintenance treatment of Crohn's disease[J].Dig Dis Sci,2000,45 (7):1462-1464.
10Guandalini S.Use of cactobacillus-GG in paediatric Crohn's disease[J].Dig Liver Dis,2002,34:63-65.
